Table 2.
Anti-glycation activity and MGO scavenging activity of LSOPC and its metabolites.
| Compounds | IC50 (mg/ mL) | MGO Scavenging |
|---|---|---|
| LSOPC | 0.035 ± 0.004 | 81.24% ± 1.15% |
| (+)-Catechin | 0.049 ± 0.019 | 78.25% ± 2.99% |
| Ferulic acid | 0.741 ± 0.013 | 12.65% ± 0.53% |
| Caffeic acid | 0.683 ± 0.012 | 14.80% ± 0.29% |
| Syringic acid | 0.720 ± 0.017 | 20.61% ± 0.01% |
| m-Coumaric acid | 4.150 ± 0.012 | 16.69% ± 0.37% |
| 3-Hydroxybenzoic acid | 2.318 ± 0.030 | 19.30% ± 0.13% |
| 3-Hydroxyphenylacetic acid | 1.126 ± 0.023 | 20.16% ± 0.25% |
| 3-Hydroxyphenylpropionic acid | 1.899 ± 0.014 | 20.72% ± 0.42% |
IC50 concentrations ± SEM were calculated as the metabolite concentration required to reduce AGE formation by 50% as determined by regression analysis (n = 3).